Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various co...
Saved in:
| Published in | Current research in pharmacology and drug discovery Vol. 3; p. 100085 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
2022
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p < 0.01) and the level of activated caspase 3/7 (p < 0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs.
[Display omitted]
•Didocosahexaenoin, an omega-3 derivative, induces cytotoxicity in prostate carcinoma cells.•The cytotoxicity induced by didocosahexaenoin in carcinoma cells was more potent than that afforded by DHA.•The likely mechanisms of cytotoxicity include an increase in the level of ROS and caspase 3/7 activity as well as an interruption in mitochondrial membrane potential. |
|---|---|
| AbstractList | The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p < 0.01) and the level of activated caspase 3/7 (p < 0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs.The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p < 0.01) and the level of activated caspase 3/7 (p < 0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs. The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p < 0.01) and the level of activated caspase 3/7 (p < 0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs. The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p < 0.01) and the level of activated caspase 3/7 (p < 0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs. [Display omitted] •Didocosahexaenoin, an omega-3 derivative, induces cytotoxicity in prostate carcinoma cells.•The cytotoxicity induced by didocosahexaenoin in carcinoma cells was more potent than that afforded by DHA.•The likely mechanisms of cytotoxicity include an increase in the level of ROS and caspase 3/7 activity as well as an interruption in mitochondrial membrane potential. The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p < 0.01) and the level of activated caspase 3/7 (p < 0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs. Image 1 • Didocosahexaenoin, an omega-3 derivative, induces cytotoxicity in prostate carcinoma cells. • The cytotoxicity induced by didocosahexaenoin in carcinoma cells was more potent than that afforded by DHA. • The likely mechanisms involve an increase in the level of ROS, caspase 3/7 activity, and loss of MMP. |
| ArticleNumber | 100085 |
| Author | Phillips, Roger M. Robinson, Glenn F. Allison, Simon J. Javid, Farideh A. Sooda, Kartheek KY |
| Author_xml | – sequence: 1 givenname: Glenn F. surname: Robinson fullname: Robinson, Glenn F. – sequence: 2 givenname: Kartheek KY surname: Sooda fullname: Sooda, Kartheek KY – sequence: 3 givenname: Roger M. surname: Phillips fullname: Phillips, Roger M. – sequence: 4 givenname: Simon J. surname: Allison fullname: Allison, Simon J. – sequence: 5 givenname: Farideh A. orcidid: 0000-0002-2775-6276 surname: Javid fullname: Javid, Farideh A. email: fajavid@hud.ac.uk |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35112078$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk9rGzEQxZeS0qRpvkEpOvYQu5J2V9rtoVBC_xgCvbRnIUsjW2ZXciV5iQ_97h3HTkl6aEEgMZr3G3jzXlZnIQaoqteMzhll4t1mbtJ2rdOcU86xRGnXPqsueNvTGW8lO3v0Pq-uct5gC5d9Q0X3ojqvW8Y4ld1F9WsRJsjFr3TxMZDoSFkDMfsSS7zzxpc98cHuDFiy3BPrbTQx6zXcaQjRh2uiUTTCSpOaWEh-Qs4E1ygi692In9sUc9EFmToZH-KoiYFhIIMPkF9Vz50eMlyd7svqx-dP32--zm6_fVncfLydmVo27QwESMmMpK3Utl5SilXeWy26pnOWAbQGXEcdg54byazEt3CWd9pyp5msL6vFkWuj3qht8qNOexW1V_eFmFZKp-LNAMrxmjPRcmEFNEtX42mRYPrW2IZKh6wPR9Z2txzBGggl6eEJ9OlP8Gu1ipPqZE8F7RDw9gRI8ecOzVejzwdPdIC4y4oLjuMFYwJb3zye9WfIw_6w4f2xwaDNOYFTuLL7VeJoPyhG1SEvaqOOeVGHvKhjXlDc_CV-4P9HdjIAcGOTh6Sy8RAwIj6BKWip_zfgNyAX3dI |
| CitedBy_id | crossref_primary_10_1002_prp2_1152 crossref_primary_10_3390_nu15092137 |
| Cites_doi | 10.1021/cr100396c 10.1016/j.cmet.2013.05.017 10.1023/A:1022945107762 10.1007/s11746-000-0179-1 10.1097/MCO.0b013e32835d2d99 10.4161/auto.7.11.16658 10.1093/jn/134.12.3412S 10.1002/biof.181 10.1126/science.1099320 10.1017/S0007114512001614 10.14312/2052-4994.2014-21 10.1002/jcp.21522 10.1002/ijc.29210 10.1002/cyto.a.21172 10.1002/jcb.24354 10.3390/nu12092751 10.1186/1471-2407-12-409 10.3390/nu7085319 10.1021/la704043g 10.1001/jama.2017.7248 10.1074/jbc.273.19.11401 10.1016/S1044-579X(02)00129-3 10.1111/j.1365-2125.2012.04374.x 10.1016/j.bpg.2011.08.001 10.1002/mnfr.201500178 10.1007/s10555-011-9299-7 10.1200/JCO.2001.19.1.191 10.1016/j.clinthera.2015.05.109 10.1177/1534735416656052 10.1021/jm991063z 10.1073/pnas.94.9.4318 10.1016/j.prostaglandins.2004.03.005 10.1038/cr.2013.115 10.1111/j.1753-4887.2010.00287.x 10.1096/fasebj.6.8.1592205 10.1016/j.ejphar.2015.03.094 10.1093/humupd/7.6.535 10.1016/j.yexcr.2010.02.039 10.1007/s12609-018-0264-0 10.1016/j.plipres.2012.10.001 10.14740/wjon1191 10.1093/ajcn/79.6.935 |
| ContentType | Journal Article |
| Copyright | 2022 Crown Copyright © 2022 Published by Elsevier B.V. Crown Copyright © 2022 Published by Elsevier B.V. 2022 |
| Copyright_xml | – notice: 2022 – notice: Crown Copyright © 2022 Published by Elsevier B.V. – notice: Crown Copyright © 2022 Published by Elsevier B.V. 2022 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.1016/j.crphar.2022.100085 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ: Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) (Open Access) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 2590-2571 |
| ExternalDocumentID | oai_doaj_org_article_f23216526d6e4bf3bf35173c95cd407f PMC8790608 35112078 10_1016_j_crphar_2022_100085 S2590257122000050 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 6I. AAEDW AAFTH AAXUO ADVLN AFJKZ AITUG ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS FDB GROUPED_DOAJ M41 M~E OK1 ROL RPM AALRI AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP APXCP CITATION 0SF NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c3745-e6e771c7057ad3b0037429da6848fd1ee5cef80f1e92c71d780f6fd28ad2fa173 |
| IEDL.DBID | DOA |
| ISSN | 2590-2571 |
| IngestDate | Wed Aug 27 01:31:49 EDT 2025 Thu Aug 21 18:28:16 EDT 2025 Fri Jul 11 06:41:19 EDT 2025 Thu Jan 02 22:37:20 EST 2025 Tue Jul 01 02:38:08 EDT 2025 Thu Apr 24 23:05:01 EDT 2025 Sun Apr 06 06:54:38 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Caspase 3/7 Prostate cancer Didocosahexaenoin Omega-3 fatty acids ROS |
| Language | English |
| License | This is an open access article under the CC BY license. Crown Copyright © 2022 Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3745-e6e771c7057ad3b0037429da6848fd1ee5cef80f1e92c71d780f6fd28ad2fa173 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2775-6276 |
| OpenAccessLink | https://doaj.org/article/f23216526d6e4bf3bf35173c95cd407f |
| PMID | 35112078 |
| PQID | 2625266116 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_f23216526d6e4bf3bf35173c95cd407f pubmedcentral_primary_oai_pubmedcentral_nih_gov_8790608 proquest_miscellaneous_2625266116 pubmed_primary_35112078 crossref_citationtrail_10_1016_j_crphar_2022_100085 crossref_primary_10_1016_j_crphar_2022_100085 elsevier_sciencedirect_doi_10_1016_j_crphar_2022_100085 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-00-00 |
| PublicationDateYYYYMMDD | 2022-01-01 |
| PublicationDate_xml | – year: 2022 text: 2022-00-00 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Current research in pharmacology and drug discovery |
| PublicationTitleAlternate | Curr Res Pharmacol Drug Discov |
| PublicationYear | 2022 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Fabbri, Amadori, Carloni, Brigliadori, Tesei (bib11) 2008; 217 Calder (bib6) 2013; 75 Coultas, Strasser (bib8) 2003; 13 Meirow, Nugent (bib40) 2001; 7 Javid, Afshinjavid (bib25) 2015; 37 Currie, Schize, Zechner, Walther, Farese (bib9) 2016; 18 Jing, Song, Shin, Kim, Jeong (bib26) 2011; 7 Kang, Wang, Yamabe, Fukui, Jay, Zhu (bib28) 2010; vol. 5 Merendino, Costantini, Manzi, Molinari, D'Eliseo, Velotti (bib41) 2013 Wall, Ross, Fitzgerald, Stanton (bib54) 2010; 68 Aucoin, Cooley, Knee, Fritz, Balneaves, Breau, Fergusson, Skidmore, Wong, Seely (bib1) 2017; 16 Green, Kroemer (bib19) 2004; 305 Rawla (bib44) 2019; 10 Cancer Research UK (bib7) 2020 Shin, Jing, Jeong, Kim, Song, Heo (bib49) 2013 Lands (bib31) 1992; 6 Zhao, Rybak, Dobucki, Traganos, Darzynkiewicz (bib56) 2011; 81A Cai, Jones (bib5) 1998; 273 D'Angelo, Motti, Meccariello (bib10) 2020; 12 Gu, Suburu, Chen, Chen (bib20) 2013 Kremer (bib30) 2001; 19 Feltes (bib12) 2010; 231 Haraldsson, Halldorsson, Kuls (bib21) 2000; 77 Serhan, Petasis (bib47) 2011; 111 Mohammad, Mustafa, Fauzia Bano (bib42) 2009; 1 Jing, Wu, Lim (bib27) 2013 So, Liu, Leung (bib51) 2015; 7 Trebelhorn, Dennis, Pondugula, Samuel, Coleman, Flannery, Morrison, Mansour (bib53) 2014; 2 Liu, Hopkins, Zhang, Quisenberry, Fix, Galvan, Meier (bib35) 2015; 352 Briscoe, Peat, McKeown, Corbett, Goetz, Littleton, McCoy (bib3) 2006; 148 Laviano, Rianda, Molfino, Fanelli (bib33) 2013; 16 Seiler, Chen, Brown, Fagundes (bib46) 2018; 10 Gleissman, Johnsen, Kogner (bib17) 2010; 316 Love, Leventhal, Easterling, Nerenz (bib37) 1989; 63 Larsson, Kumlin, Sundberg, Wolk (bib32) 2004; 79 Reis, Miller, Leser, Watzke, Fainerman, Holmberg (bib45) 2008; 24 Siddiqui, Harvey, Xu, Bammerlin, Walker, Altenburg (bib50) 2011; 37 Fenton, Weyrich, Durbin, Liu, Bang, Melnikow (bib13) 2018 Im (bib24) 2016; 785 Ly, Grubb, Lawen (bib38) 2003; 8 Hopkins, Meier (bib22) 2017; 2336 Litwin, Tan (bib34) 2017; 317 Hull (bib23) 2011; 25 Liu, Yang, Yao, Chia, Lu (bib36) 2016; 60 Brown, Cascio, Rotondo, Pertwee, Heys, Wahle (bib4) 2013; 52 Kliewer, Sundseth, Jones, Brown, Wisely (bib29) 1997; 29 Gerber (bib16) 2012; 107 Marino, Kroemer (bib39) 2013; 23 Wang, Liu, Jiang, Wei, Niu, Wang, Zhang, Meng, Yao (bib55) 2016; 2016 Terry, Terry, Rohan (bib52) 2004; 134 Berquin (bib2) 2011; 30 Serhan, Gotlinger, Hong, Arita (bib48) 2004; 73 Ferlay, Soerjomataram, Dikshit, Eser, Mathers, Rebelo, Parkin, Forman, Bray (bib14) 2015; 136 Phillips, Naylor, Jaffar, Doughty, Everett, Breen (bib43) 1999; 42 Goc, Kochuparambil, Al-Husein, Al-Azayzih, Mohammad, Somanath (bib18) 2012 Fukui, Kang, Okada, Zhu (bib15) 2013; 114 Lands (10.1016/j.crphar.2022.100085_bib31) 1992; 6 Im (10.1016/j.crphar.2022.100085_bib24) 2016; 785 Terry (10.1016/j.crphar.2022.100085_bib52) 2004; 134 Litwin (10.1016/j.crphar.2022.100085_bib34) 2017; 317 Liu (10.1016/j.crphar.2022.100085_bib36) 2016; 60 Goc (10.1016/j.crphar.2022.100085_bib18) 2012 Kremer (10.1016/j.crphar.2022.100085_bib30) 2001; 19 Fenton (10.1016/j.crphar.2022.100085_bib13) 2018 Hull (10.1016/j.crphar.2022.100085_bib23) 2011; 25 Currie (10.1016/j.crphar.2022.100085_bib9) 2016; 18 Reis (10.1016/j.crphar.2022.100085_bib45) 2008; 24 Cai (10.1016/j.crphar.2022.100085_bib5) 1998; 273 Jing (10.1016/j.crphar.2022.100085_bib26) 2011; 7 Meirow (10.1016/j.crphar.2022.100085_bib40) 2001; 7 Berquin (10.1016/j.crphar.2022.100085_bib2) 2011; 30 Ferlay (10.1016/j.crphar.2022.100085_bib14) 2015; 136 Kliewer (10.1016/j.crphar.2022.100085_bib29) 1997; 29 Calder (10.1016/j.crphar.2022.100085_bib6) 2013; 75 Wall (10.1016/j.crphar.2022.100085_bib54) 2010; 68 Brown (10.1016/j.crphar.2022.100085_bib4) 2013; 52 Larsson (10.1016/j.crphar.2022.100085_bib32) 2004; 79 Trebelhorn (10.1016/j.crphar.2022.100085_bib53) 2014; 2 Green (10.1016/j.crphar.2022.100085_bib19) 2004; 305 Gu (10.1016/j.crphar.2022.100085_bib20) 2013 Seiler (10.1016/j.crphar.2022.100085_bib46) 2018; 10 Rawla (10.1016/j.crphar.2022.100085_bib44) 2019; 10 Wang (10.1016/j.crphar.2022.100085_bib55) 2016; 2016 Phillips (10.1016/j.crphar.2022.100085_bib43) 1999; 42 So (10.1016/j.crphar.2022.100085_bib51) 2015; 7 Laviano (10.1016/j.crphar.2022.100085_bib33) 2013; 16 Merendino (10.1016/j.crphar.2022.100085_bib41) 2013 Marino (10.1016/j.crphar.2022.100085_bib39) 2013; 23 Siddiqui (10.1016/j.crphar.2022.100085_bib50) 2011; 37 Shin (10.1016/j.crphar.2022.100085_bib49) 2013 Fukui (10.1016/j.crphar.2022.100085_bib15) 2013; 114 Ly (10.1016/j.crphar.2022.100085_bib38) 2003; 8 Aucoin (10.1016/j.crphar.2022.100085_bib1) 2017; 16 Gleissman (10.1016/j.crphar.2022.100085_bib17) 2010; 316 Gerber (10.1016/j.crphar.2022.100085_bib16) 2012; 107 Fabbri (10.1016/j.crphar.2022.100085_bib11) 2008; 217 Haraldsson (10.1016/j.crphar.2022.100085_bib21) 2000; 77 Javid (10.1016/j.crphar.2022.100085_bib25) 2015; 37 Mohammad (10.1016/j.crphar.2022.100085_bib42) 2009; 1 Cancer Research UK (10.1016/j.crphar.2022.100085_bib7) 2020 Coultas (10.1016/j.crphar.2022.100085_bib8) 2003; 13 Zhao (10.1016/j.crphar.2022.100085_bib56) 2011; 81A Kang (10.1016/j.crphar.2022.100085_bib28) 2010; vol. 5 Jing (10.1016/j.crphar.2022.100085_bib27) 2013 Serhan (10.1016/j.crphar.2022.100085_bib47) 2011; 111 Serhan (10.1016/j.crphar.2022.100085_bib48) 2004; 73 D'Angelo (10.1016/j.crphar.2022.100085_bib10) 2020; 12 |
| References_xml | – volume: 7 start-page: 535 year: 2001 end-page: 543 ident: bib40 article-title: The effects of radiotherapy and chemotherapy on female reproduction publication-title: Hum. Reprod. Update – start-page: 1 year: 2013 end-page: 11 ident: bib41 article-title: Dietary ω-3 Polyunsaturated Fatty Acid DHA: A Potential Adjuvant in the Treatment of Cancer – volume: 19 start-page: 191 year: 2001 end-page: 196 ident: bib30 article-title: Anthracycline-induced clinical heart failure in a Cohort of 607 Children: long-term follow-up study publication-title: J. Clin. Oncol. – volume: 73 start-page: 155 year: 2004 end-page: 172 ident: bib48 article-title: Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis publication-title: Prostag. Other Lipid Mediat. – volume: 2336 start-page: 233 year: 2017 end-page: 251 ident: bib22 article-title: Free fatty acid receptors and cancer: from Nutrition to pharmacology publication-title: Handb. Exp. Pharmacol. – volume: 75 start-page: 645 year: 2013 end-page: 662 ident: bib6 article-title: Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? publication-title: Br. J. Clin. Pharmacol. – volume: 24 start-page: 5781 year: 2008 end-page: 5786 ident: bib45 article-title: Adsorption of polar lipids at the Water−Oil interface publication-title: Langmuir – year: 2013 ident: bib27 article-title: Omega-3 Polyunsaturated Fatty Acids and Cancer. Anti-cancer Agents in Medicinal Chemistry – volume: 2016 year: 2016 ident: bib55 article-title: Bach1 induces endothelial cell apoptosis and cell-cycle arrest through ROS generation publication-title: Oxidat. Med. Cell. Longev. – volume: 217 start-page: 494 year: 2008 end-page: 501 ident: bib11 article-title: Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells publication-title: J. Cell. Physiol. – volume: 23 start-page: 1247 year: 2013 end-page: 1248 ident: bib39 article-title: Mechanisms of apoptotic phosphatidylserine exposure publication-title: Cell Res. – volume: 148 start-page: 619 year: 2006 end-page: 628 ident: bib3 article-title: Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40:identification of agonist and antagonist small molecules publication-title: Br. J. Pharmacol. – volume: 2 start-page: 132 year: 2014 end-page: 143 ident: bib53 article-title: Plant-based omega-3 stearidonic acid enhances antitumor activity of doxorubicin in human prostate cancer cell lines publication-title: J. Canc. Res. Ther. – volume: 136 start-page: E359 year: 2015 end-page: E386 ident: bib14 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLABOCAN 2012 publication-title: Int. J. Cancer – start-page: 11 year: 2013 ident: bib49 article-title: The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53 publication-title: BioMed Res. Int. – volume: 7 start-page: 6956 year: 2015 end-page: 6973 ident: bib51 article-title: Omega-3 polyunsaturated fatty acids trigger cell cycle arrest and induces apoptosis in human neuroblastoma LA-N-1 cells publication-title: Nutrients – volume: 37 start-page: e35 year: 2015 ident: bib25 article-title: The effect of fluoxetine on human ovarian carcinoma cells publication-title: Clin. Therapeut. – volume: 37 start-page: 399 year: 2011 end-page: 412 ident: bib50 article-title: Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects publication-title: Biofactors – volume: 77 start-page: 1139 year: 2000 end-page: 1145 ident: bib21 article-title: Chemoenzymatic synthesis of structured triacylglycerols containing eicosapentaenoic and docosahexaenoic acids publication-title: JAOCS (J. Am. Oil Chem. Soc.) – volume: 352 start-page: 380 year: 2015 end-page: 394 ident: bib35 article-title: Omega-3 fatty acids and other FFA4 agonists inhibit growth factor signalling in human prostate cancer cells publication-title: J. Pharmacol. Exp. Therapeut. – volume: 305 start-page: 626 year: 2004 end-page: 629 ident: bib19 article-title: The pathophysiology of mitochondrial cell death publication-title: Science – volume: 16 start-page: 32 year: 2017 end-page: 62 ident: bib1 article-title: Fish-Derived omega-3 fatty acids and prostate cancer: a systemic review publication-title: Integr. Cancer Ther. – volume: 18 start-page: 153 year: 2016 end-page: 161 ident: bib9 article-title: Cellular fatty acid metabolism and cancer publication-title: Cell Metabol. – volume: 29 start-page: 4318 year: 1997 end-page: 4323 ident: bib29 article-title: Fatty acids and ecosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma publication-title: Proc. Natl. Acad. Sci. Unit. States Am. – volume: 134 start-page: 3412S year: 2004 end-page: 3420S ident: bib52 article-title: Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research publication-title: J. Nutr. – volume: 60 start-page: 430 year: 2016 end-page: 443 ident: bib36 article-title: Docosahexaenoic acid inhibits inflammation via free fatty acid receptor FFA4, disruption of TAB2 interaction with TAK1/TAB1 and downregulation of ERK-dependent Egr-1 expression in EA.hy926 cells publication-title: Mol. Nutr. Food Res. – volume: 52 start-page: 80 year: 2013 end-page: 109 ident: bib4 article-title: Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators publication-title: Prog. Lipid Res. – volume: 785 start-page: 36 year: 2016 end-page: 43 ident: bib24 article-title: Functions of omega-3-fatty acids and FFA4 (GPR120) in macrophages publication-title: Eur. J. Pharmacol. – volume: 68 start-page: 280 year: 2010 end-page: 289 ident: bib54 article-title: Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids publication-title: Nutr. Rev. – volume: 7 start-page: 1348 year: 2011 end-page: 1358 ident: bib26 article-title: Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53 publication-title: Autophagy – volume: 8 start-page: 115 year: 2003 end-page: 128 ident: bib38 article-title: The mitochondrial membrane potential (δψm) in apoptosis; an update publication-title: Apoptosis – year: 2018 ident: bib13 article-title: Prostate-specific Antigen-Based Screening for Prostate Cancer: a Systemic Evidence Review for the US Prevention Services Task Force – volume: 13 start-page: 115 year: 2003 end-page: 123 ident: bib8 article-title: The role of Bcl-2 protein family in cancer publication-title: Semin. Cancer Biol. – volume: 63 start-page: 604 year: 1989 end-page: 612 ident: bib37 article-title: Side effects and emotional distress during cancer chemotherapy publication-title: Cancer – start-page: 1 year: 2013 end-page: 10 ident: bib20 article-title: Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention publication-title: BioMed Res. Int. – volume: 10 start-page: 14 year: 2018 end-page: 27 ident: bib46 article-title: Obesity, dietary factors, nutrition, and breast cancer risk publication-title: Curr. Breast Canc. Rep. – volume: 42 start-page: 4071 year: 1999 end-page: 4080 ident: bib43 article-title: Bioreductive activation of a series of indolequinones by human DT-diaphorase:Structure−Activity relationships publication-title: J. Med. Chem. – volume: 16 start-page: 156 year: 2013 end-page: 161 ident: bib33 article-title: Omega-3 fatty acids in cancer publication-title: Curr. Opin. Clin. Nutr. Metab. Care – volume: 12 start-page: 2751 year: 2020 end-page: 2762 ident: bib10 article-title: omega-3 and omega-6 polyunsatturated fatty acids, obesity and cancer publication-title: Nutrients – year: 2020 ident: bib7 article-title: Treatment options for prostate cancer publication-title: Treatment options for prostate cancer – volume: 317 start-page: 2532 year: 2017 end-page: 2542 ident: bib34 article-title: The Diagnoses and treatment of prostate cancer: a review publication-title: JAMA – volume: 273 start-page: 11401 year: 1998 end-page: 11404 ident: bib5 article-title: Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss publication-title: J. Biol. Chem. – volume: 25 start-page: 547 year: 2011 end-page: 554 ident: bib23 article-title: Omega-3 polyunsaturated fatty acids publication-title: Best Pract. Res. Clin. Gastroenterol. – volume: 79 start-page: 935 year: 2004 end-page: 945 ident: bib32 article-title: Dietary long-chain n−3 fatty acids for the prevention of cancer: a review of potential mechanisms publication-title: Am. J. Clin. Nutr. – volume: 6 start-page: 2530 year: 1992 end-page: 2536 ident: bib31 article-title: Biochemistry and physiology of n-3 fatty acids publication-title: Faseb. J. – volume: 10 start-page: 63 year: 2019 end-page: 89 ident: bib44 article-title: Epidemiology of prostate cancer publication-title: World J. Oncol. – volume: 30 start-page: 295 year: 2011 end-page: 309 ident: bib2 article-title: Polyunsaturated fatty acid metabolism in prostate cancer publication-title: Cancer Metastasis Rev. – volume: vol. 5 start-page: e10296 year: 2010 ident: bib28 article-title: Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation publication-title: PloS One – volume: 81A start-page: 45 year: 2011 end-page: 51 ident: bib56 article-title: Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide publication-title: Cytometry – volume: 316 start-page: 1365 year: 2010 end-page: 1373 ident: bib17 article-title: Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? publication-title: Exp. Cell Res. – volume: 1 start-page: 178 year: 2009 end-page: 199 ident: bib42 article-title: Cancer: possible prevention and chemotherapy by fatty materials: (A review) publication-title: Arch. Appl. Sci. Res. – start-page: 409 year: 2012 end-page: 415 ident: bib18 article-title: Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis publication-title: BMC Cancer – volume: 114 start-page: 192 year: 2013 end-page: 203 ident: bib15 article-title: EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction publication-title: J. Cell. Biochem. – volume: 231 start-page: 701 year: 2010 end-page: 710 ident: bib12 article-title: Assessment of process parameters on the production of diglycerides rich in omega-3 fatty acids through the enzymatic glycerolysis of fish oil publication-title: Eur. Food Res. Technol. – volume: 107 start-page: S228 year: 2012 end-page: S239 ident: bib16 article-title: Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies publication-title: Br. J. Nutr. – volume: 111 start-page: 5922 year: 2011 end-page: 5943 ident: bib47 article-title: Resolvins and protectins in inflammation resolution publication-title: Chem. Rev. – volume: 111 start-page: 5922 issue: 10 year: 2011 ident: 10.1016/j.crphar.2022.100085_bib47 article-title: Resolvins and protectins in inflammation resolution publication-title: Chem. Rev. doi: 10.1021/cr100396c – volume: 18 start-page: 153 issue: 2 year: 2016 ident: 10.1016/j.crphar.2022.100085_bib9 article-title: Cellular fatty acid metabolism and cancer publication-title: Cell Metabol. doi: 10.1016/j.cmet.2013.05.017 – volume: 8 start-page: 115 issue: 2 year: 2003 ident: 10.1016/j.crphar.2022.100085_bib38 article-title: The mitochondrial membrane potential (δψm) in apoptosis; an update publication-title: Apoptosis doi: 10.1023/A:1022945107762 – volume: 77 start-page: 1139 issue: 11 year: 2000 ident: 10.1016/j.crphar.2022.100085_bib21 article-title: Chemoenzymatic synthesis of structured triacylglycerols containing eicosapentaenoic and docosahexaenoic acids publication-title: JAOCS (J. Am. Oil Chem. Soc.) doi: 10.1007/s11746-000-0179-1 – volume: 16 start-page: 156 issue: 2 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib33 article-title: Omega-3 fatty acids in cancer publication-title: Curr. Opin. Clin. Nutr. Metab. Care doi: 10.1097/MCO.0b013e32835d2d99 – volume: 7 start-page: 1348 issue: 11 year: 2011 ident: 10.1016/j.crphar.2022.100085_bib26 article-title: Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53 publication-title: Autophagy doi: 10.4161/auto.7.11.16658 – volume: 134 start-page: 3412S issue: 12 year: 2004 ident: 10.1016/j.crphar.2022.100085_bib52 article-title: Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research publication-title: J. Nutr. doi: 10.1093/jn/134.12.3412S – volume: vol. 5 start-page: e10296 year: 2010 ident: 10.1016/j.crphar.2022.100085_bib28 article-title: Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation – start-page: 1 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib41 – volume: 37 start-page: 399 issue: 6 year: 2011 ident: 10.1016/j.crphar.2022.100085_bib50 article-title: Docosahexaenoic acid: a natural powerful adjuvant that improves efficacy for anticancer treatment with no adverse effects publication-title: Biofactors doi: 10.1002/biof.181 – year: 2020 ident: 10.1016/j.crphar.2022.100085_bib7 article-title: Treatment options for prostate cancer – volume: 305 start-page: 626 issue: 5684 year: 2004 ident: 10.1016/j.crphar.2022.100085_bib19 article-title: The pathophysiology of mitochondrial cell death publication-title: Science doi: 10.1126/science.1099320 – volume: 107 start-page: S228 issue: Suppl. 2 year: 2012 ident: 10.1016/j.crphar.2022.100085_bib16 article-title: Omega-3 fatty acids and cancers: a systematic update review of epidemiological studies publication-title: Br. J. Nutr. doi: 10.1017/S0007114512001614 – volume: 1 start-page: 178 issue: 2 year: 2009 ident: 10.1016/j.crphar.2022.100085_bib42 article-title: Cancer: possible prevention and chemotherapy by fatty materials: (A review) publication-title: Arch. Appl. Sci. Res. – volume: 2 start-page: 132 issue: 9 year: 2014 ident: 10.1016/j.crphar.2022.100085_bib53 article-title: Plant-based omega-3 stearidonic acid enhances antitumor activity of doxorubicin in human prostate cancer cell lines publication-title: J. Canc. Res. Ther. doi: 10.14312/2052-4994.2014-21 – volume: 217 start-page: 494 issue: 2 year: 2008 ident: 10.1016/j.crphar.2022.100085_bib11 article-title: Mitotic catastrophe and apoptosis induced by docetaxel in hormone-refractory prostate cancer cells publication-title: J. Cell. Physiol. doi: 10.1002/jcp.21522 – start-page: 1 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib20 article-title: Mechanisms of omega-3 polyunsaturated fatty acids in prostate cancer prevention publication-title: BioMed Res. Int. – volume: 136 start-page: E359 issue: 5 year: 2015 ident: 10.1016/j.crphar.2022.100085_bib14 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLABOCAN 2012 publication-title: Int. J. Cancer doi: 10.1002/ijc.29210 – volume: 81A start-page: 45 issue: 1 year: 2011 ident: 10.1016/j.crphar.2022.100085_bib56 article-title: Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide publication-title: Cytometry doi: 10.1002/cyto.a.21172 – volume: 2016 issue: Special issue year: 2016 ident: 10.1016/j.crphar.2022.100085_bib55 article-title: Bach1 induces endothelial cell apoptosis and cell-cycle arrest through ROS generation publication-title: Oxidat. Med. Cell. Longev. – volume: 114 start-page: 192 issue: 1 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib15 article-title: EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction publication-title: J. Cell. Biochem. doi: 10.1002/jcb.24354 – volume: 12 start-page: 2751 issue: 9 year: 2020 ident: 10.1016/j.crphar.2022.100085_bib10 article-title: omega-3 and omega-6 polyunsatturated fatty acids, obesity and cancer publication-title: Nutrients doi: 10.3390/nu12092751 – start-page: 409 issue: 12 year: 2012 ident: 10.1016/j.crphar.2022.100085_bib18 article-title: Simultaneous modulation of the intrinsic and extrinsic pathways by simvastatin in mediating prostate cancer cell apoptosis publication-title: BMC Cancer doi: 10.1186/1471-2407-12-409 – volume: 7 start-page: 6956 issue: 8 year: 2015 ident: 10.1016/j.crphar.2022.100085_bib51 article-title: Omega-3 polyunsaturated fatty acids trigger cell cycle arrest and induces apoptosis in human neuroblastoma LA-N-1 cells publication-title: Nutrients doi: 10.3390/nu7085319 – volume: 24 start-page: 5781 issue: 11 year: 2008 ident: 10.1016/j.crphar.2022.100085_bib45 article-title: Adsorption of polar lipids at the Water−Oil interface publication-title: Langmuir doi: 10.1021/la704043g – volume: 317 start-page: 2532 issue: 24 year: 2017 ident: 10.1016/j.crphar.2022.100085_bib34 article-title: The Diagnoses and treatment of prostate cancer: a review publication-title: JAMA doi: 10.1001/jama.2017.7248 – volume: 273 start-page: 11401 issue: 19 year: 1998 ident: 10.1016/j.crphar.2022.100085_bib5 article-title: Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss publication-title: J. Biol. Chem. doi: 10.1074/jbc.273.19.11401 – volume: 13 start-page: 115 issue: 2 year: 2003 ident: 10.1016/j.crphar.2022.100085_bib8 article-title: The role of Bcl-2 protein family in cancer publication-title: Semin. Cancer Biol. doi: 10.1016/S1044-579X(02)00129-3 – volume: 75 start-page: 645 issue: 3 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib6 article-title: Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? publication-title: Br. J. Clin. Pharmacol. doi: 10.1111/j.1365-2125.2012.04374.x – volume: 25 start-page: 547 issue: 4–5 year: 2011 ident: 10.1016/j.crphar.2022.100085_bib23 article-title: Omega-3 polyunsaturated fatty acids publication-title: Best Pract. Res. Clin. Gastroenterol. doi: 10.1016/j.bpg.2011.08.001 – volume: 60 start-page: 430 issue: 2 year: 2016 ident: 10.1016/j.crphar.2022.100085_bib36 article-title: Docosahexaenoic acid inhibits inflammation via free fatty acid receptor FFA4, disruption of TAB2 interaction with TAK1/TAB1 and downregulation of ERK-dependent Egr-1 expression in EA.hy926 cells publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.201500178 – volume: 30 start-page: 295 issue: 3 year: 2011 ident: 10.1016/j.crphar.2022.100085_bib2 article-title: Polyunsaturated fatty acid metabolism in prostate cancer publication-title: Cancer Metastasis Rev. doi: 10.1007/s10555-011-9299-7 – volume: 19 start-page: 191 issue: 1 year: 2001 ident: 10.1016/j.crphar.2022.100085_bib30 article-title: Anthracycline-induced clinical heart failure in a Cohort of 607 Children: long-term follow-up study publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2001.19.1.191 – volume: 37 start-page: e35 issue: 8, Suppl. ment year: 2015 ident: 10.1016/j.crphar.2022.100085_bib25 article-title: The effect of fluoxetine on human ovarian carcinoma cells publication-title: Clin. Therapeut. doi: 10.1016/j.clinthera.2015.05.109 – start-page: 11 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib49 article-title: The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53 publication-title: BioMed Res. Int. – volume: 16 start-page: 32 issue: 1 year: 2017 ident: 10.1016/j.crphar.2022.100085_bib1 article-title: Fish-Derived omega-3 fatty acids and prostate cancer: a systemic review publication-title: Integr. Cancer Ther. doi: 10.1177/1534735416656052 – volume: 42 start-page: 4071 issue: 20 year: 1999 ident: 10.1016/j.crphar.2022.100085_bib43 article-title: Bioreductive activation of a series of indolequinones by human DT-diaphorase:Structure−Activity relationships publication-title: J. Med. Chem. doi: 10.1021/jm991063z – volume: 29 start-page: 4318 issue: 9 year: 1997 ident: 10.1016/j.crphar.2022.100085_bib29 article-title: Fatty acids and ecosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma publication-title: Proc. Natl. Acad. Sci. Unit. States Am. doi: 10.1073/pnas.94.9.4318 – volume: 73 start-page: 155 issue: 3–4 year: 2004 ident: 10.1016/j.crphar.2022.100085_bib48 article-title: Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis publication-title: Prostag. Other Lipid Mediat. doi: 10.1016/j.prostaglandins.2004.03.005 – volume: 23 start-page: 1247 issue: 11 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib39 article-title: Mechanisms of apoptotic phosphatidylserine exposure publication-title: Cell Res. doi: 10.1038/cr.2013.115 – volume: 68 start-page: 280 issue: 5 year: 2010 ident: 10.1016/j.crphar.2022.100085_bib54 article-title: Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids publication-title: Nutr. Rev. doi: 10.1111/j.1753-4887.2010.00287.x – volume: 6 start-page: 2530 issue: 8 year: 1992 ident: 10.1016/j.crphar.2022.100085_bib31 article-title: Biochemistry and physiology of n-3 fatty acids publication-title: Faseb. J. doi: 10.1096/fasebj.6.8.1592205 – volume: 785 start-page: 36 year: 2016 ident: 10.1016/j.crphar.2022.100085_bib24 article-title: Functions of omega-3-fatty acids and FFA4 (GPR120) in macrophages publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2015.03.094 – volume: 7 start-page: 535 issue: 6 year: 2001 ident: 10.1016/j.crphar.2022.100085_bib40 article-title: The effects of radiotherapy and chemotherapy on female reproduction publication-title: Hum. Reprod. Update doi: 10.1093/humupd/7.6.535 – volume: 316 start-page: 1365 issue: 8 year: 2010 ident: 10.1016/j.crphar.2022.100085_bib17 article-title: Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2010.02.039 – volume: 10 start-page: 14 year: 2018 ident: 10.1016/j.crphar.2022.100085_bib46 article-title: Obesity, dietary factors, nutrition, and breast cancer risk publication-title: Curr. Breast Canc. Rep. doi: 10.1007/s12609-018-0264-0 – volume: 52 start-page: 80 issue: 1 year: 2013 ident: 10.1016/j.crphar.2022.100085_bib4 article-title: Cannabinoids and omega-3/6 endocannabinoids as cell death and anticancer modulators publication-title: Prog. Lipid Res. doi: 10.1016/j.plipres.2012.10.001 – volume: 10 start-page: 63 issue: 2 year: 2019 ident: 10.1016/j.crphar.2022.100085_bib44 article-title: Epidemiology of prostate cancer publication-title: World J. Oncol. doi: 10.14740/wjon1191 – year: 2013 ident: 10.1016/j.crphar.2022.100085_bib27 – volume: 79 start-page: 935 issue: 6 year: 2004 ident: 10.1016/j.crphar.2022.100085_bib32 article-title: Dietary long-chain n−3 fatty acids for the prevention of cancer: a review of potential mechanisms publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/79.6.935 – year: 2018 ident: 10.1016/j.crphar.2022.100085_bib13 |
| SSID | ssj0002794068 |
| Score | 2.169305 |
| Snippet | The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 100085 |
| SubjectTerms | Caspase 3/7 Didocosahexaenoin Omega-3 fatty acids Prostate cancer ROS |
| Title | Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines |
| URI | https://dx.doi.org/10.1016/j.crphar.2022.100085 https://www.ncbi.nlm.nih.gov/pubmed/35112078 https://www.proquest.com/docview/2625266116 https://pubmed.ncbi.nlm.nih.gov/PMC8790608 https://doaj.org/article/f23216526d6e4bf3bf35173c95cd407f |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV07b9swECaKTFmKNn25j-AKFJksVC8-NLZFgiBAiwwJkI2g-GgUNGJQO0U85L_3SEqOnA5eCmiwZVH06T7pPorH7wj51LaGirYpMsFEm9XO2kxohl9drpSiuMXcnO8_2PF5fXJBLyalvkJOWJIHThfus8OQXzBaMsNs3boKN1rwSjdUGxyMuPD0xZg3GUxdxem0BiNVLEdHmzxDXBbjurmY3KXRCBXkQMsy5AnkoZTyJC5F-f6N8PQv_XycRTkJS0fPyNOBT8KXZMdz8sT2e-TgNAlSr-Zw9rC-ajGHAzh9kKpevSD3E5kN34N3gHwQ9Grpl_6u08jQAcfs6H0D7QpMZ7z2C3Vp75TtfdfPQWGja_tTQQUGsfwnyojPsRHE4n9wExaVIJ0FHWoW9f5aQZgqgEBuFy_J-dHh2bfjbCjIkOmK1zSzzHJeaI4cT5mqjdo1ZWMUE7VwprCWautE7grblJoXhuNn5kwplCmdQq-9Iju97-0bAk7rvDHBtZUKHK6hlNWCtkwwyo0SM1KN7pB6UCsPRTN-yTEt7UomJ8rgRJmcOCPZutVNUuvYcvzX4On1sUFrO-5ABMoBgXIbAmeEjziRA21JdARP1W3p_uMIK4l3dbj-qrf-diFLHJYG6lSwGXmdYLb-k2Hqt0Rmh_1uAHDDis1f-u4yKocL3uQsF2__h9nvyG4wJb2Oek92lr9v7QckaMt2P96L-_HN2V_6AjsN |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Investigation+of+the+cytotoxicity+induced+by+didocosahexaenoin%2C+an+omega+3+derivative%2C+in+human+prostate+carcinoma+cell+lines&rft.jtitle=Current+research+in+pharmacology+and+drug+discovery&rft.au=Robinson%2C+Glenn+F.&rft.au=Sooda%2C+Kartheek+KY&rft.au=Phillips%2C+Roger+M.&rft.au=Allison%2C+Simon+J.&rft.date=2022&rft.pub=Elsevier+B.V&rft.issn=2590-2571&rft.eissn=2590-2571&rft_id=info:doi/10.1016%2Fj.crphar.2022.100085&rft.externalDocID=S2590257122000050 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2590-2571&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2590-2571&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2590-2571&client=summon |